HIPP RAYMOND R 4
4 · NEOGENOMICS INC · Filed Nov 18, 2020
Insider Transaction Report
Form 4
HIPP RAYMOND R
Director
Transactions
- Sale
Common Stock
2020-11-16$42.28/sh−70,000$2,959,600→ 66,800 total
Holdings
- 3,448
Stock Option (Right to Buy)
Exercise: $28.54From: 2021-05-28Exp: 2027-05-28→ Common Stock (3,448 underlying) - 3,334
Stock Option (Right to Buy)
Exercise: $7.27Exp: 2022-05-25→ Common Stock (3,334 underlying) - 4,269
Stock Option (Right to Buy)
Exercise: $22.52From: 2020-06-06Exp: 2026-06-06→ Common Stock (4,269 underlying)
Footnotes (1)
- [F1]On May 25, 2017, Mr. Hipp was granted 10,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.